Elutia Inc (NAS:ELUT)
$ 3.22 0 (0%) Market Cap: 78.41 Mil Enterprise Value: 88.08 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 47/100

Q2 2021 Aziyo Biologics Inc Earnings Call Transcript

Aug 09, 2021 / 08:30PM GMT
Release Date Price: $8.3 (+2.22%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Aziyo Biologics Q2 2021 Earnings Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker for today. Leigh Salvo, you may begin.

Leigh J. Salvo
Gilmartin Group LLC - MD

Thank you, and thank you all for participating in today's call. Joining me are Ron Lloyd, Chief Executive Officer; and Matt Ferguson, Chief Financial Officer. Earlier today, Aziyo released financial results for the second quarter ended June 30, 2021. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that do not relate to matters of historical fact or relate to expectations or predictions of future events, results or performance are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot